Rheumatoid Arthritis
Showing NaN - NaN of 113
Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol)
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol
-
Palm Desert, California
- +66 more
Mar 16, 2020
Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol)
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol
-
Huntsville, Alabama
- +120 more
Mar 16, 2020
Rheumatoid Arthritis Trial in Worldwide (PF-06650833, Placebo, Tofacitinib)
Rheumatoid Arthritis, Arthritis, Rheumatoid Trial in Worldwide (JHL1101, MabThera)
Terminated
- Rheumatoid Arthritis
- Arthritis, Rheumatoid
- JHL1101
- MabThera
-
Banja Luka, Bosnia and Herzegovina
- +31 more
Jan 6, 2020
Rheumatoid Arthritis Trial in Worldwide (CP-690,550, Methotrexate, Placebo)
Rheumatoid Arthritis Trial in Worldwide (Baricitinib, Methotrexate, Baricitinib Placebo)
Rheumatoid Arthritis Trial in Worldwide (Adalimumab, Baricitinib, Methotrexate)
Rheumatoid Arthritis Trial in Worldwide (Etanercept, CHS-0214)
Completed
- Rheumatoid Arthritis
-
Phoenix, Arizona
- +140 more
Jun 7, 2019
Rheumatoid Arthritis Trial in Belarus, India, Russian Federation (BCD-055, Remicade®, Methotrexate)
Completed
- Rheumatoid Arthritis
- BCD-055
- +3 more
-
Minsk, Belarus
- +38 more
Jun 12, 2019
Rheumatoid Arthritis Trial in Worldwide (BMS-986142, Placebo, Methotrexate)
Rheumatoid Arthritis Trial in Worldwide (Placebo, JNJ-38518168 (3 mg), JNJ-38518168 (10 mg))
Terminated
- Rheumatoid Arthritis
- Placebo
- +4 more
-
Huntsville, Alabama
- +86 more
Mar 13, 2019
Rheumatoid Arthritis Trial in Worldwide (Namilumab, Adalimumab, Methotrexate)
Rheumatoid Arthritis Trial in Worldwide (PF-06410293, Adalimumab)
Completed
- Rheumatoid Arthritis
- PF-06410293
- Adalimumab
-
Gilbert, Arizona
- +182 more
Jan 18, 2019
Rheumatoid Arthritis Trial in Worldwide (PF-04171327 10 mg, Prednisone Placebo, PF-04171327 25 mg)
Completed
- Rheumatoid Arthritis
- PF-04171327 10 mg
- +5 more
-
Anniston, Alabama
- +37 more
Nov 30, 2018
Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )
Terminated
- Inflammation
- Rheumatoid Arthritis
- NNC0109-0012
- placebo
-
Huntington Beach, California
- +139 more
Sep 3, 2018
Rheumatoid Arthritis Trial in Worldwide (PF-06438179, Infliximab)
Completed
- Rheumatoid Arthritis
- PF-06438179
- Infliximab
-
Birmingham, Alabama
- +183 more
Apr 30, 2018